logo Sigma Diagnostics has acquired Amelung GmbH of Lemgo, Germany. We’ve been the exclusive worldwide distributor of Amelung instruments since 1996, and believe this acquisition clearly shows our strong commitment to the coagulation market. We now have full ownership of the research and development, instrumentation, reagents and controls that will benefit our customers for many years to come. Our automated systems, like AMAX 190 Plus™ and AMAX 400 Plus™, meet testing needs in both physicians’ offices and in the largest hospitals and laboratories. They also allow hospital and reference laboratories to provide prompt and accurate results to physicians during surgery or while diagnosing life threatening thrombotic medical disorders.
     Sigma Diagnostics has also acquired First Medical, Inc. of Mountain View, California, which enhances our already strong presence in the cardiac testing market and provides a strong entry position in the emerging point-of-care market. Since 1993 FMI has been developing rapid diagnostic testing that will significantly improve medical outcomes and lower healthcare costs. The Alpha DX, a rapid immunoassay system, provides quick and accurate results to diagnose Acute Myocardial Infarction. It will be used with Sigma Diagnostics reagents in hospital emergency rooms, coronary care units and physicians’ offices to quickly and easily provide quantitative results that distinguish heart attacks from other benign causes of chest pain. The system has received F.D.A. clearance and is expected to be available for sale in early 2001.
Phone: 800-325-3424 or